Go to main content

Press Releases

Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com 

AOP Orphan to market the innovative antiarrhythmic drug BRINAVESS® exclusively in Central Europe

25. 8. 2014

Internationally renowned pharmaceutical expert Hans Peter Hasler strengthens AOP Orphan Supervisory Board

2. 5. 2014

Partnership between AOP Orphan and Ferrer: Joint marketing of Adasuve® in CEE

10. 7. 2013

AOP Orphan Expands and Enlarges the Management Team

10. 7. 2013

AOP Orphan Pharmaceuticals announces progress of pivotal phase III trial PROUD-PV of novel mono-pegylated Interferon alpha 2b for the treatment of Polycythemia vera

10. 7. 2013

AOP Orphan expands its range of special cardiovascular preparations

4. 7. 2013